Haemoperfusion in the treatment of chronic renal failure in patients on haemodialysis.
The paper is concerned with materials characterizing physicochemical properties of haemosorbents of varying grades. Adsorption of different uraemic toxins was studied. The possibility of microembolization of internal organs and tissues with haemosorbent particles was explored in the course of prolonged treatment with the use of haemosorption. Different approaches to connecting the sorption column to the dialyzer were examined to disclose an optimal variant. The authors report the results of applying haemosorption in patients who had received haemodialysis therapy to prevent complications. The blood response to the prolonged haemosorption treatment was analyzed. It is recommended that long-term (6-7 hours) sessions of haemosorption might be performed using carbons having high sorption capacity.
D000293:Adolescent; D000327:Adsorption; D000328:Adult; D002606:Charcoal / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D005260:Female; D006464:Hemoperfusion; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D008297:Male; D006435:Renal Dialysis; D014527:Uric Acid / Q000097:blood; D014805:Vitamin B 12 / Q000097:blood
D002606:Charcoal; D014527:Uric Acid; D003404:Creatinine; D014805:Vitamin B 12